and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Clovis Oncology Stock Price (Quote) NASDAQ:CLVS
$2.41 ( -15.44% ) Tuesday, 5th Jul 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.58 | $2.90 | Tuesday, 5th Jul 2022 CLVS stock ended at $2.41. This is 15.44% less than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 15.61% from a day low at $2.37 to a day high of $2.74. |
| 90 days | $0.58 | $3.14 | |
| 52 weeks | $0.58 | $5.92 |
Historical Clovis Oncology prices
| Date | Open | High | Low | Close | Volume |
| 2022-07-05 | $2.70 | $2.74 | $2.37 | $2.41 | 26 858 837 |
| 2022-07-01 | $2.02 | $2.90 | $1.99 | $2.85 | 73 614 404 |
| 2022-06-30 | $1.68 | $1.95 | $1.63 | $1.80 | 12 546 063 |
| 2022-06-29 | $1.69 | $1.71 | $1.55 | $1.71 | 4 214 723 |
| 2022-06-28 | $1.70 | $1.85 | $1.62 | $1.71 | 7 424 579 |
| 2022-06-27 | $1.81 | $1.81 | $1.57 | $1.71 | 8 291 814 |
| 2022-06-24 | $1.66 | $1.91 | $1.66 | $1.70 | 27 277 835 |
| 2022-06-23 | $1.40 | $1.77 | $1.34 | $1.74 | 19 380 796 |
| 2022-06-22 | $1.74 | $1.84 | $1.47 | $1.53 | 30 674 078 |
| 2022-06-21 | $1.30 | $2.40 | $1.28 | $1.64 | 110 032 472 |
| 2022-06-17 | $0.89 | $1.20 | $0.88 | $1.18 | 19 379 200 |
| 2022-06-16 | $0.90 | $0.92 | $0.83 | $0.89 | 6 972 239 |
| 2022-06-15 | $0.86 | $1.01 | $0.78 | $0.97 | 21 149 045 |
| 2022-06-14 | $0.89 | $1.12 | $0.80 | $0.81 | 64 161 093 |
| 2022-06-13 | $0.66 | $0.73 | $0.58 | $0.70 | 10 166 487 |
| 2022-06-10 | $0.71 | $0.72 | $0.65 | $0.66 | 3 425 143 |
| 2022-06-09 | $0.78 | $0.80 | $0.73 | $0.73 | 3 017 906 |
| 2022-06-08 | $0.73 | $0.82 | $0.71 | $0.78 | 4 630 399 |
| 2022-06-07 | $0.68 | $0.75 | $0.66 | $0.73 | 3 917 682 |
| 2022-06-06 | $0.76 | $0.76 | $0.66 | $0.67 | 5 365 018 |
| 2022-06-03 | $0.66 | $0.76 | $0.64 | $0.75 | 6 941 058 |
| 2022-06-02 | $0.66 | $0.67 | $0.64 | $0.65 | 3 031 699 |
| 2022-06-01 | $0.70 | $0.72 | $0.64 | $0.67 | 4 118 224 |
| 2022-05-31 | $0.70 | $0.74 | $0.65 | $0.70 | 4 595 859 |
| 2022-05-27 | $0.72 | $0.72 | $0.62 | $0.69 | 4 544 538 |
| 2022-05-26 | $0.65 | $0.69 | $0.65 | $0.67 | 3 022 050 |
| 2022-05-25 | $0.65 | $0.69 | $0.63 | $0.67 | 2 436 591 |
| 2022-05-24 | $0.68 | $0.69 | $0.61 | $0.63 | 3 025 156 |
| 2022-05-23 | $0.72 | $0.74 | $0.68 | $0.68 | 3 386 774 |
| 2022-05-20 | $0.74 | $0.74 | $0.66 | $0.71 | 4 409 775 |
| 2022-05-19 | $0.75 | $0.76 | $0.69 | $0.71 | 3 658 239 |
| 2022-05-18 | $0.79 | $0.80 | $0.71 | $0.74 | 3 836 512 |
| 2022-05-17 | $0.84 | $0.87 | $0.78 | $0.78 | 5 778 790 |
| 2022-05-16 | $0.80 | $0.86 | $0.76 | $0.83 | 4 572 994 |
| 2022-05-13 | $0.81 | $0.84 | $0.77 | $0.78 | 3 820 894 |
| 2022-05-12 | $0.75 | $0.79 | $0.70 | $0.76 | 5 700 516 |
| 2022-05-11 | $0.86 | $0.86 | $0.72 | $0.75 | 5 777 501 |
| 2022-05-10 | $0.87 | $0.92 | $0.83 | $0.85 | 9 741 472 |
| 2022-05-09 | $0.94 | $1.00 | $0.80 | $0.81 | 14 605 119 |
| 2022-05-06 | $1.42 | $1.43 | $0.96 | $0.99 | 37 345 623 |
| 2022-05-05 | $1.63 | $1.63 | $1.40 | $1.47 | 6 508 801 |
| 2022-05-04 | $1.69 | $1.73 | $1.54 | $1.68 | 12 382 319 |
| 2022-05-03 | $2.03 | $2.16 | $2.01 | $2.10 | 5 312 520 |
| 2022-05-02 | $1.97 | $2.11 | $1.86 | $2.03 | 6 357 749 |
| 2022-04-29 | $2.06 | $2.16 | $1.98 | $2.00 | 5 999 156 |
| 2022-04-28 | $2.32 | $2.32 | $2.01 | $2.14 | 5 748 442 |
| 2022-04-27 | $2.31 | $2.35 | $2.21 | $2.25 | 3 723 488 |
| 2022-04-26 | $2.42 | $2.44 | $2.24 | $2.29 | 4 086 106 |
| 2022-04-25 | $2.15 | $2.48 | $2.13 | $2.44 | 5 909 973 |
| 2022-04-22 | $2.17 | $2.29 | $2.12 | $2.17 | 2 957 859 |
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. It is developing three product candidates, which include Rociletinib, an oral epidermal growth factor receptor and mutant-selective covalent inhibitor that is under review with the U.S. and E.U. regulatory authorities for the treatment of non-small cell lung cancer; Rucapar... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
